Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Vivos Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 29 | 28 | −1 |
| Shares | 2.23M | 2.49M | +251.8K (+11.3%) |
| Value | $5.02M | $6.66M | +$1.63M (+32.5%) |
New holders (6)
Institutions that held Vivos Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 170,264 | $456.0K | 0.00% |
| Millennium Management LLC | 11,244 | $30.0K | 0.00% |
| Renaissance Technologies LLC | 10,900 | $29.0K | 0.00% |
| Simplex Trading, LLC | 3,645 | $9.00K | 0.00% |
| IFP Advisors, Inc | 150 | $1.00K | 0.00% |
| Global Retirement Partners, LLC | 570 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Vivos Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Anson Funds Management LP | 122,297 | $275.0K |
| Two Sigma Investments, LP | 117,215 | $264.0K |
| Citadel Advisors LLC | 26,063 | $59.0K |
| Cambridge Investment Research Advisors, Inc. | 19,200 | $43.0K |
| UBS Group AG | 17,083 | $38.0K |
| Avalon Investment & Advisory | 15,269 | $34.0K |
| Bank of America Corp | 26 | $0 |